These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 30894570)
21. PGE Lin MC; Chen SY; Tsai HM; He PL; Lin YC; Herschman H; Li HJ Stem Cells; 2017 Feb; 35(2):425-444. PubMed ID: 27506158 [TBL] [Abstract][Full Text] [Related]
22. Generation of ROS by CAY10598 leads to inactivation of STAT3 signaling and induction of apoptosis in human colon cancer HCT116 cells. Chae IG; Kim DH; Kundu J; Jeong CH; Kundu JK; Chun KS Free Radic Res; 2014 Nov; 48(11):1311-21. PubMed ID: 25096910 [TBL] [Abstract][Full Text] [Related]
23. Crosstalk between the COX2-PGE2-EP4 signaling pathway and primary cilia in osteoblasts after mechanical stimulation. Li YH; Zhu D; Yang T; Cheng L; Sun J; Tan L J Cell Physiol; 2021 Jun; 236(6):4764-4777. PubMed ID: 33275302 [TBL] [Abstract][Full Text] [Related]
24. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism. Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855 [TBL] [Abstract][Full Text] [Related]
25. PGE2 released by primary sensory neurons modulates Toll-like receptor 4 activities through an EP4 receptor-dependent process. Tse KH; Chow KBS; Wise H J Neuroimmunol; 2016 Apr; 293():8-16. PubMed ID: 27049555 [TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway. Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834 [TBL] [Abstract][Full Text] [Related]
27. The induction of S100p expression by the Prostaglandin E₂ (PGE₂)/EP4 receptor signaling pathway in colon cancer cells. Chandramouli A; Mercado-Pimentel ME; Hutchinson A; Gibadulinová A; Olson ER; Dickinson S; Shañas R; Davenport J; Owens J; Bhattacharyya AK; Regan JW; Pastorekova S; Arumugam T; Logsdon CD; Nelson MA Cancer Biol Ther; 2010 Nov; 10(10):1056-66. PubMed ID: 20890108 [TBL] [Abstract][Full Text] [Related]
28. Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer. Kochel TJ; Reader JC; Ma X; Kundu N; Fulton AM Oncotarget; 2017 Jan; 8(4):6540-6554. PubMed ID: 28029661 [TBL] [Abstract][Full Text] [Related]
29. Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue. Tang EH; Cai Y; Wong CK; Rocha VZ; Sukhova GK; Shimizu K; Xuan G; Vanhoutte PM; Libby P; Xu A J Lipid Res; 2015 Feb; 56(2):358-68. PubMed ID: 25510249 [TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor. Aoudjit L; Potapov A; Takano T Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1534-42. PubMed ID: 16396944 [TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells. Hawcroft G; Ko CW; Hull MA Oncogene; 2007 May; 26(21):3006-19. PubMed ID: 17130837 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of lysyl oxidase by prostaglandin E2 via EP2/EP4 receptors in human amnion fibroblasts: Implications for parturition. Liu C; Zhu P; Wang W; Li W; Shu Q; Chen ZJ; Myatt L; Sun K Mol Cell Endocrinol; 2016 Mar; 424():118-27. PubMed ID: 26826430 [TBL] [Abstract][Full Text] [Related]
33. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells. Cherukuri DP; Chen XB; Goulet AC; Young RN; Han Y; Heimark RL; Regan JW; Meuillet E; Nelson MA Exp Cell Res; 2007 Aug; 313(14):2969-79. PubMed ID: 17631291 [TBL] [Abstract][Full Text] [Related]
34. Modulation of PGE2-induced EP4 expression on snail signaling and the impact on epithelial-mesenchymal transition: significance of EP4 antagonism. Kim HN; Narayanan NK; Lasano S; Narayanan B Anticancer Res; 2011 Dec; 31(12):4347-57. PubMed ID: 22199300 [TBL] [Abstract][Full Text] [Related]
35. The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas. Wei J; Zhang J; Wang D; Cen B; Lang JD; DuBois RN Cancer Prev Res (Phila); 2022 May; 15(5):285-296. PubMed ID: 35121582 [TBL] [Abstract][Full Text] [Related]
36. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification. Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101 [TBL] [Abstract][Full Text] [Related]
37. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells. Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899 [TBL] [Abstract][Full Text] [Related]
38. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition. Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001 [TBL] [Abstract][Full Text] [Related]
40. PGE(2) induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activation. Yang L; Junmin S; Hong Y; Shuodong W Ann Hepatol; 2013; 12(3):479-86. PubMed ID: 23619266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]